Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study Comparing the Efficacy and Safety of Standard of Care With or Without Siltuximab in Selected Hospitalized Patients With Viral Acute Respiratory Distress Syndrome (SILVAR)

NCT04616586 is registered in ClinicalTrials.gov with RECORDATI GROUP as lead sponsor.

NCT NCT04616586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04616586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study Comparing the Efficacy and Safety of Standard of Care With or Without Siltuximab in Selected Hospitalized Patients With Viral Acute Respiratory Distress Syndrome (SILVAR)
Lead sponsor
RECORDATI GROUP
Phase
Phase 3
Overall status
Terminated
Start date
November 13, 2020
Completion date
April 1, 2021
Enrollment
555 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, lung diseases, pneumonia, respiratory tract disease, respiratory tract infections